LFCR
Lifecore Biomedical Inc.
6.50$
-1.1%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 37.4% | 33.7% | 31.2% | 37.0% | 31.9% | 30.1% | 32.1% | 35.4% | 35.8% | 35.7% | 34.4% | 36.5% | |
| 1.2% | 3.5% | 1.3% | 7.5% | 3.3% | 2.2% | 3.7% | 2.3% | 3.5% | 8.0% | 9.2% | 7.5% | |
| 1.2% | – | – | 7.5% | 3.3% | 2.2% | 3.7% | 2.3% | 3.5% | 8.0% | 9.2% | 7.5% | |
| 13.7% | 10.8% | 12.3% | 11.4% | 12.3% | 10.2% | 7.9% | 8.1% | 18.2% | 12.4% | 11.9% | 13.3% | |
| 20.6% | 17.0% | 16.9% | 16.1% | 15.7% | 16.9% | 15.4% | 14.6% | 13.5% | 14.4% | 12.5% | 11.1% | |
| 51.2% | – | – | – | – | – | – | – | – | – | – | – | |
| 5.9% | 5.7% | 5.6% | 5.5% | 5.5% | 5.6% | 5.4% | 5.8% | 5.8% | 5.9% | 6.2% | 6.0% | |
| 1.9% | 1.7% | 1.7% | 1.7% | 1.7% | 1.7% | 1.6% | 1.8% | 1.8% | 1.8% | 1.9% | – | |
| 85.5% | 105.5% | 99.4% | 101.7% | 95.5% | 101.6% | 94.0% | 99.1% | 99.4% | 84.4% | 90.8% | 93.0% | |
| 16.0% | 14.4% | 16.4% | 15.5% | 15.3% | 16.4% | 13.8% | 13.1% | 12.6% | 12.7% | 9.1% | 9.4% | |
| 0.6% | – | – | 0.7% | 1.9% | 2.0% | 1.9% | 2.1% | 1.6% | 0.6% | 0.6% | 0.4% | |
| 6.3% | 6.4% | 7.7% | 8.7% | 6.4% | 7.3% | 5.9% | 3.1% | 3.4% | 4.3% | 2.9% | 3.3% | |
| 41.9% | 43.6% | 44.3% | 45.8% | 47.5% | 51.5% | 46.6% | 52.2% | 53.1% | 57.4% | 63.0% | 64.7% | |
| 14.5% | -5.5% | 0.6% | -1.7% | 4.5% | -1.6% | 6.0% | 0.9% | 0.6% | 15.6% | 9.2% | 7.0% | |
| -59.3% | -77.1% | -71.2% | -70.4% | -65.6% | -74.0% | -75.0% | -85.9% | -85.8% | -92.7% | -105.6% | -106.5% | |
| 12.8% | 12.4% | 12.4% | 12.0% | 12.0% | 12.5% | 13.5% | 15.6% | 15.5% | 15.9% | 16.6% | 16.4% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.